Monoclonal Antibodies against SARS-CoV-2: Potential Game-Changer Still Underused

Even several months after the start of a massive vaccination campaign against COVID-19, mortality and hospital admission are still high in many countries. Monoclonal antibodies against SARS-CoV-2 are the ideal complement to vaccination in infected subjects who are at high risk for progression to sev...

Full description

Saved in:
Bibliographic Details
Main Authors: Ivan Gentile, Alberto Enrico Maraolo, Antonio Riccardo Buonomo, Mariano Nobile, Prisco Piscitelli, Alessandro Miani, Nicola Schiano Moriello
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
R
Online Access:https://doaj.org/article/b7fb01da7b214bbf9105986b0f8ace84
Tags: Add Tag
No Tags, Be the first to tag this record!